电针对心房颤动患者脑电信号的影响

注册号:

Registration number:

ITMCTR2025000022

最近更新日期:

Date of Last Refreshed on:

2025-01-07

注册时间:

Date of Registration:

2025-01-07

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

电针对心房颤动患者脑电信号的影响

Public title:

The effect of electroacupuncture on EEG signals in patients with atrial fibrillation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针对心房颤动患者脑电信号的影响

Scientific title:

The effect of electroacupuncture on EEG signals in patients with atrial fibrillation

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王菁菁

研究负责人:

崔海明

Applicant:

Jingjing Wang

Study leader:

Haiming Cui

申请注册联系人电话:

Applicant telephone:

13587651193

研究负责人电话:

Study leader's telephone:

13918927624

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

jjwangtcm@163.com

研究负责人电子邮件:

Study leader's E-mail:

cuihaiming@shyueyanghospital.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市虹口区甘河路110号

研究负责人通讯地址:

上海市虹口区甘河路110号

Applicant address:

110 Ganhe Road Hongkou District Shanghai

Study leader's address:

110 Ganhe Road Hongkou District Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海中医药大学附属岳阳中西医结合医院

Applicant's institution:

Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2024-145

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

上海中医药大学附属岳阳中西医结合医院伦理委员会

Name of the ethic committee:

Ethics Committee of Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2024/5/31 0:00:00

伦理委员会联系人:

殷从全

Contact Name of the ethic committee:

Congquan Yin

伦理委员会联系地址:

上海市虹口区甘河路110号

Contact Address of the ethic committee:

110 Ganhe Road Hongkou District Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 65161782

伦理委员会联系人邮箱:

Contact email of the ethic committee:

yyyyllwyh@163.com

研究实施负责(组长)单位:

上海中医药大学附属岳阳中西医结合医院

Primary sponsor:

Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine

研究实施负责(组长)单位地址:

上海市虹口区甘河路110号

Primary sponsor's address:

110 Ganhe Road Hongkou District Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

虹口区

Country:

China

Province:

Shanghai

City:

Hongkou

单位(医院):

上海中医药大学附属岳阳中西医结合医院

具体地址:

上海市虹口区甘河路110号

Institution
hospital:

Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine

Address:

110 Ganhe Road Hongkou District Shanghai

经费或物资来源:

课题

Source(s) of funding:

project

研究疾病:

心房颤动

研究疾病代码:

Target disease:

atrial fibrillation

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

探索针刺对心房颤动患者脑电图的影响,以及对心电图、血压等多方面的影响。了解大脑对于应激刺激的反应与心血管功能。

Objectives of Study:

Explore the effects of acupuncture on the electroencephalogram (EEG) of patients with atrial fibrillation as well as its effects on various aspects such as electrocardiogram (ECG) and blood pressure. Understand the brain's response to stress stimuli and cardiovascular function.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)年龄≥18岁且≤85岁,性别不限; (2)符合心房颤动及气虚血瘀证的诊断标准; (3)理解、同意参加本研究并签署知情同意书。

Inclusion criteria

(1) Age ≥ 18 years old and ≤ 85 years old gender not limited; (2) Meets the diagnostic criteria for atrial fibrillation and qi deficiency and blood stasis syndrome; (3) Understand and agree to participate in this study and sign the informed consent form.

排除标准:

(1)妊娠、哺乳期的妇女,或未避孕的育龄期妇女; (2)转氨酶大于最高上限3倍; (3)血肌酐大于177umol/L; (4)3个月内新发脑梗死、脑出血或脑肿瘤等脑部疾病; (5)一周内服用过精神类药物; (6)既往接受过针灸治疗。

Exclusion criteria:

(1) Pregnant or lactating women or women of childbearing age who have not used contraception; (2) The transaminase is greater than three times the maximum limit; (3) Blood creatinine is greater than 177umol/L; (4) Newly diagnosed brain diseases such as cerebral infarction cerebral hemorrhage or brain tumors within 3 months; (5) Have taken psychotropic drugs within one week; (6) He has received acupuncture and moxibustion treatment in the past.

研究实施时间:

Study execute time:

From 2024-08-01

To      2025-06-01

征募观察对象时间:

Recruiting time:

From 2024-08-01

To      2025-06-01

干预措施:

Interventions:

组别:

B

样本量:

15

Group:

B

Sample size:

干预措施:

假电针

干预措施代码:

Intervention:

simulant EA group

Intervention code:

组别:

A

样本量:

15

Group:

A

Sample size:

干预措施:

电针

干预措施代码:

Intervention:

Electroacupuncture

Intervention code:

样本总量 Total sample size : 30

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海市

市(区县):

Country:

China

Province:

shanghai

City:

单位(医院):

上海中医药大学附属岳阳中西医结合医院

单位级别:

三甲

Institution/hospital:

Shanghai University of Traditional Chinese Medicine Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine

Level of the institution:

A-Class Hospital

测量指标:

Outcomes:

指标中文名:

脑电信号

指标类型:

主要指标

Outcome:

EEG signal

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

heart rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血压

指标类型:

次要指标

Outcome:

blood pressure

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肝功能

指标类型:

副作用指标

Outcome:

liver function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肾功能

指标类型:

副作用指标

Outcome:

kidney function

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 85
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

random number table

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

no

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统